John Clayton Taylor - Sep 28, 2022 Form 3 Insider Report for IDERA PHARMACEUTICALS, INC. (IDRA)

Role
Chief Executive Officer, Director
Signature
/s/ John J. Kirby, Attorney-in-Fact for John Clayton Taylor
Stock symbol
IDRA
Transactions as of
Sep 28, 2022
Transactions value $
$0
Form type
3
Date filed
9/30/2022, 09:45 PM
Next filing
Jan 19, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney